| Dr Graham Thomas Atkins, MD | |
|
1 Medical Center Dr, Dhmc, Department Of Pulmonary Medicine, Lebanon, NH 03756 | |
| (603) 650-5218 | |
| Not Available |
| Full Name | Dr Graham Thomas Atkins |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 19 Years |
| Location | 1 Medical Center Dr, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346576246 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 042.0014179 (Vermont) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 17676 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dartmouth-hitchcock Clinic | 4183537509 | 1139 |
| Mary Hitchcock Memorial Hospital | 4486561164 | 964 |
News Archive
Swiss Post Solutions, a leading outsourcing provider for business process solutions and innovative services in document management, and IMMJ Systems were selected by Kingston Hospital NHS Foundation Trust to deliver a multi-speciality service to improve patient care through instant access to clinical information; improved integration; and collaboration between clinicians.
Both positive and negative experiences influence how genetic variants affect the brain and thereby behaviour, according to a new study. "Evidence is accumulating to show that the effects of variants of many genes that are common in the population depend on environmental factors.
Four years back on his visit to the United States, Pope Benedict XVI blessed a box of silver ribbon-shaped pins for breast cancer charity Susan G. Komen for the Cure and sent them to its founder, Nancy Brinker. Brinker was touched by the gesture and thanked the pontiff in person on the day of his departure.
As part of a series about Americans' response to the H1N1 flu outbreak, the Harvard Opinion Research Program at the Harvard School of Public Health is releasing a national poll that focuses on Americans' views and concerns about the potential for a more severe outbreak of Influenza A (H1N1) in the fall or winter. The polling was done June 22-28, 2009.
Aradigm Corporation today announced that the Company's Investigational New Drug Application (IND) to conduct a pivotal Phase 3 clinical trial of Pulmaquin (dual release ciprofloxacin for inhalation) in non-cystic fibrosis bronchiectasis (BE) has been cleared by the U.S. Food and Drug Administration.
› Verified 3 days ago
| Entity Name | Mary Hitchcock Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023092053 PECOS PAC ID: 4486561164 Enrollment ID: O20031126000258 |
News Archive
Swiss Post Solutions, a leading outsourcing provider for business process solutions and innovative services in document management, and IMMJ Systems were selected by Kingston Hospital NHS Foundation Trust to deliver a multi-speciality service to improve patient care through instant access to clinical information; improved integration; and collaboration between clinicians.
Both positive and negative experiences influence how genetic variants affect the brain and thereby behaviour, according to a new study. "Evidence is accumulating to show that the effects of variants of many genes that are common in the population depend on environmental factors.
Four years back on his visit to the United States, Pope Benedict XVI blessed a box of silver ribbon-shaped pins for breast cancer charity Susan G. Komen for the Cure and sent them to its founder, Nancy Brinker. Brinker was touched by the gesture and thanked the pontiff in person on the day of his departure.
As part of a series about Americans' response to the H1N1 flu outbreak, the Harvard Opinion Research Program at the Harvard School of Public Health is releasing a national poll that focuses on Americans' views and concerns about the potential for a more severe outbreak of Influenza A (H1N1) in the fall or winter. The polling was done June 22-28, 2009.
Aradigm Corporation today announced that the Company's Investigational New Drug Application (IND) to conduct a pivotal Phase 3 clinical trial of Pulmaquin (dual release ciprofloxacin for inhalation) in non-cystic fibrosis bronchiectasis (BE) has been cleared by the U.S. Food and Drug Administration.
› Verified 3 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
Swiss Post Solutions, a leading outsourcing provider for business process solutions and innovative services in document management, and IMMJ Systems were selected by Kingston Hospital NHS Foundation Trust to deliver a multi-speciality service to improve patient care through instant access to clinical information; improved integration; and collaboration between clinicians.
Both positive and negative experiences influence how genetic variants affect the brain and thereby behaviour, according to a new study. "Evidence is accumulating to show that the effects of variants of many genes that are common in the population depend on environmental factors.
Four years back on his visit to the United States, Pope Benedict XVI blessed a box of silver ribbon-shaped pins for breast cancer charity Susan G. Komen for the Cure and sent them to its founder, Nancy Brinker. Brinker was touched by the gesture and thanked the pontiff in person on the day of his departure.
As part of a series about Americans' response to the H1N1 flu outbreak, the Harvard Opinion Research Program at the Harvard School of Public Health is releasing a national poll that focuses on Americans' views and concerns about the potential for a more severe outbreak of Influenza A (H1N1) in the fall or winter. The polling was done June 22-28, 2009.
Aradigm Corporation today announced that the Company's Investigational New Drug Application (IND) to conduct a pivotal Phase 3 clinical trial of Pulmaquin (dual release ciprofloxacin for inhalation) in non-cystic fibrosis bronchiectasis (BE) has been cleared by the U.S. Food and Drug Administration.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Graham Thomas Atkins, MD 1 Medical Center Dr, Dhmc, Department Of Pulmonary Medicine, Lebanon, NH 03756-1000 Ph: (603) 650-5533 | Dr Graham Thomas Atkins, MD 1 Medical Center Dr, Dhmc, Department Of Pulmonary Medicine, Lebanon, NH 03756 Ph: (603) 650-5218 |
News Archive
Swiss Post Solutions, a leading outsourcing provider for business process solutions and innovative services in document management, and IMMJ Systems were selected by Kingston Hospital NHS Foundation Trust to deliver a multi-speciality service to improve patient care through instant access to clinical information; improved integration; and collaboration between clinicians.
Both positive and negative experiences influence how genetic variants affect the brain and thereby behaviour, according to a new study. "Evidence is accumulating to show that the effects of variants of many genes that are common in the population depend on environmental factors.
Four years back on his visit to the United States, Pope Benedict XVI blessed a box of silver ribbon-shaped pins for breast cancer charity Susan G. Komen for the Cure and sent them to its founder, Nancy Brinker. Brinker was touched by the gesture and thanked the pontiff in person on the day of his departure.
As part of a series about Americans' response to the H1N1 flu outbreak, the Harvard Opinion Research Program at the Harvard School of Public Health is releasing a national poll that focuses on Americans' views and concerns about the potential for a more severe outbreak of Influenza A (H1N1) in the fall or winter. The polling was done June 22-28, 2009.
Aradigm Corporation today announced that the Company's Investigational New Drug Application (IND) to conduct a pivotal Phase 3 clinical trial of Pulmaquin (dual release ciprofloxacin for inhalation) in non-cystic fibrosis bronchiectasis (BE) has been cleared by the U.S. Food and Drug Administration.
› Verified 3 days ago
Elias Loukas, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dhmc Section Of Hospital Medicine, Lebanon, NH 03756 Phone: 603-650-8380 | |
Dr. Michael W Winter, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Drive, Gastroenterology, Lebanon, NH 03756 Phone: 603-650-5261 | |
Hannah Elizabeth Foote Bensimhon, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Victoria Forbes, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5516 | |
Zanira Fazal, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 18 Old Etna Rd, Lebanon, NH 03766 Phone: 603-650-4000 | |
Susan Si-yao Wang, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dartmouth-hitchcock Medical Ctr, Department Of Medicine, Lebanon, NH 03756 Phone: 603-650-9480 | |
Mark Edward Splaine, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Dhmc Section Of General Internal Medicine, Lebanon, NH 03756 Phone: 603-653-9500 |